IMF Chairman Dr. Brian Durie weighed in on the high cost of cancer drugs after the recent article in Mayo Clinic Proceedings. He discusses what needs to be done within the healthcare system to better serve the patients.

Previous Post
Bringing Next Generation Flow (NGF) Cytometry to Japan
Next Post
What Is the Solution for the Rising Cost of Cancer Drugs?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.